Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
format_facet:"Aufsätze"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
publishDate:"[2010 TO 2019]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
PubPharm (572)
1
Ixazomib citrate-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib citrate or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; a randomized phase II trial : Ixazomib citrate-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib citrate or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; a randomized phase II trial - HOVON 126 MM
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
2
Multicenter Open label Phase 2 study of Isatuximab plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma : Multicenter Open label Phase 2 study of Isatuximab plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma - IsKPd-IFM2018-03
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis : A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared With CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
4
A phase III trial to compare standard and frailty-adjusted induction therapy with ixazomib, lenalidomide and dexamethasone (IRD) and maintenance lenalidomide (R) to lenalidomide plus ixazomib (R+I) : Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma: A phase III trial to compare standard and frailty-adjusted induction therapy with ixazomib, lenalidomide and dexamethasone (IRD) and maintenance lenalidomide (R) to lenalidomide plus ixazomib (R+I). - Myeloma XIV (FiTNEss)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
5
A MULTICENTER, OPEN LABEL, RANDOMIZED PHASE II STUDY COMPARING DARATUMUMAB combined with BORTEZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE (Dara-VCd) VERSUS THE ASSOCIATION OF BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTd) AS PRE TRANSPLANT INDUCTION AND POST TRANSPLANT CONSOLIDATION, BOTH FOLLOWED BY A MAINTENANCE PHASE WITH IXAZOMIB ALONE OR IN COMBINATION WITH DARATUMUMAB, IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) YOUNG PATIENTS eligible for AUTOLOGOUS STEM CELL TRANSPLANTATION : A MULTICENTER, OPEN LABEL, RANDOMIZED PHASE II STUDY COMPARING DARATUMUMAB combined with BORTEZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE (Dara-VCd) VERSUS THE ASSOCIATION OF BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTd) AS PRE TRANSPLANT INDUCTION AND POST TRANSPLANT CONSOLIDATION, BOTH FOLLOWED BY A MAINTENANCE PHASE WITH IXAZOMIB ALONE OR IN COMBINATION WITH DARATUMUMAB, IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) YOUNG PATIENTS eligible for AUTOLOGOUS STEM CELL TRANSPLANTATION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis : A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared With CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
7
Ixazomib citrate-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib citrate or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; a randomized phase II trial : Ixazomib citrate-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib citrate or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; a randomized phase II trial - HOVON 126 MM
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
8
Multicenter Open label Phase 2 study of Isatuximab plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma : Multicenter Open label Phase 2 study of Isatuximab plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma - IsKPd-IFM2018-03
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
9
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis : A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared With CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
10
A phase III trial to compare standard and frailty-adjusted induction therapy with ixazomib, lenalidomide and dexamethasone (IRD) and maintenance lenalidomide (R) to lenalidomide plus ixazomib (R+I) : Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma: A phase III trial to compare standard and frailty-adjusted induction therapy with ixazomib, lenalidomide and dexamethasone (IRD) and maintenance lenalidomide (R) to lenalidomide plus ixazomib (R+I). - Myeloma XIV (FiTNEss)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[58]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Filter aufheben
Erscheinungsjahr: 2010-2019
Medienart
Aufsätze
572
E-Artikel
572
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
572
610
Recruitment Status: Authorised-recruitment may ...
572
Study Type: Interventional
184
Phase: Phase 3
62
Phase: Phase 2
42
Phase: Phase 4
10
Medical Condition: AL Amyloidosis (Newly Diagno...
10
Medical Condition: Multiple Myeloma MedDRA vers...
10
Phase: Phase 1
8
Medical Condition: Multiple Myeloma MedDRA vers...
8
Medical Condition: Relapsed or Refractory Multi...
6
Medical Condition: AL Amyloidosis (Newly Diagno...
6
Medical Condition: Atopic Dermatitis MedDRA ver...
6
Medical Condition: Multiple Myeloma
6
Medical Condition: Patient with chronic lymphoc...
6
Medical Condition: Patients with Relapsed Refra...
6
Medical Condition: Relapsed or Refractory Multi...
6
Medical Condition: Relapsed or Refractory Multi...
4
Medical Condition: Cirrhotic patients under vas...
4
Medical Condition: Encephalopathy with electric...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
124
2019
94
2018
46
2017
54
2016
44
2015
42
2014
30
2013
138
2012
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
544
Englisch
14
Unbestimmt
8
Französisch
4
Dänisch
2
Spanisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...